IN FISH, SKELETAL MUSCLE GROWTH can occur throughout the entire life cycle through both hyperplasia and hypertrophy. This sets fish apart from all other vertebrate classes, where postnatal growth is by means of hypertrophy (31, 32, 63, 67) . Therefore, fish also represent an important model for studying fundamental growth-regulatory mechanisms in vertebrates.
The insulin-like growth factor-I (IGF-I) is a key regulatory hormone that controls growth in vertebrates (70) . Particularly, skeletal muscle growth is strongly stimulated by this hormone (19) . IGF-I stimulates both proliferation and differentiation of myoblasts (14) , as well as promoting myotube hypertrophy in vitro and in vivo (46, 55, 56) . The mitogenic and anabolic effects of IGF-I on muscle cells are mediated through specific binding with the IGF-I receptor (IGF-IR) (38) . This ligandreceptor interaction promotes the activation of two major intracellular signaling pathways, the mitogen-activated protein kinases (MAPKs), specifically the extracellular signal-regulated kinase (ERK), and the phosphatidylinositol 3 kinase (PI3K)/Akt (21, 22) . The MAPK (RAF/MEK/ERK) is a key signaling pathway in skeletal muscle, where its activation is absolutely indispensable for muscle cell proliferation (14, 30) . Specifically, the serine/threonine kinase ERK is a central and main component in this pathway (16) . This kinase activates a wide variety of substrates that regulate transcription and translation, controlling cell cycle and fate decisions (16, 42) . In mammals, the inactivation of ERK1/2 in myoblasts, through the over expression of dominant-negative mutants of Raf-1, prevents myoblast proliferation (39) . Furthermore, ERK is a positive regulator of myogenesis, and its presence and activation is required for myoblast terminal differentiation (39) . Hence, ERK phosphorylation is a key marker of the activation of the RAF/MEK/ERK signaling pathway and muscle growth (56) . The PI3K/Akt pathway is also important in muscle, promoting crucial roles such as protein synthesis (55) , myoblast differentiation (14) , and muscle hypertrophy (5, 21, 22) . Also, this pathway has a significant role in the inhibition of protein degradation by means of the inhibition of FOXO transcription factors, blocking the upregulation of E3 ubiquitin ligases MuRF1 and MAFbx/atrogin (23) . Particularly, the serine/threonine kinase Akt (also known as protein kinase B) is a critical signaling node within all cells of higher eukaryotes, and one of the most important and versatile protein kinases (40) . The Akt activation modulates the function of numerous downstream substrates involved in the regulation of cell survival and growth (40) . In mammals, the activation of Akt is sufficient to induce muscle hypertrophy, as demonstrated in transgenic mice expressing a constitutively active form of Akt in muscle (36) . Therefore, Akt phosphorylation is an important marker of the activation of the PI3K/Akt pathway and skeletal muscle growth (55) . In fish, IGF-I is able to activate the MAPK/ERK and the PI3K/Akt pathways in primary cultures of myosatellite cells (20, 19, 43) . However, the evaluation of these pathways in vivo and their contribution to somatic growth has not been previously studied.
Skeletal muscle growth is also strongly influenced by nutrition by means of enhancing protein synthesis and accretion (69) . The molecular mechanisms through which nutrition reg-ulates muscle growth are being clarified in mammals. For instance, amino acids modulate the activation of intracellular pathways by activating the mammalian target of rapamycin (mTOR) (48, 49) , a downstream component of the PI3K/Akt pathway. In addition, IGF-I stimulates amino acid uptake in myosatellite cells (9, 54) , as well as activating mTOR via the PI3K/Akt signaling pathway, demonstrating the importance and interaction of both hormonal and nutritional signaling in skeletal muscle mass regulation. On the other hand, the effects of nutrition on the activation of the MAPK/ERK pathway in muscle are less well defined. In mammals, a caloric restriction protocol modifies the activation of this pathway in muscle (47) . In fish, nutritional regulation of the PI3K/Akt pathway has been demonstrated (57, 58) , whereas the influence of nutrition on the MAPK/ERK pathway is unknown.
Fish exhibit great capacity for compensatory growth following fasting periods, allowing fasted fish to rapidly catch-up in size with continuously fed fish, once the feeding of fasted fish is resumed (52) . Not only do these well-defined periods of rapid growth allow for in vivo studies that elucidate the intracellular mechanisms involved in compensatory growth, which have not yet been described, but also allow for clarifying the nutritional and endocrine regulation of skeletal muscle growth. Endocrine regulation of compensatory growth has been proposed as a key system to explain the dynamic of this phenomenon (7, 15, 20, 44, 50, 53, 61) . It is well known that the GH/IGF-I axis is affected by nutrient availability, where the majority of its components, such as IGF-I, IGF-II, IGFBP, IGF-IR, GH, and GHR, switch differentially during fasting and/or refeeding (7, 20, 44, 61) .
The aim of this work was to evaluate the IGF-I/MAPK/ERK and the IGF-I/PI3K/Akt pathways in skeletal muscle as well as study the nutrient-mediated activation of these pathways in vivo using the fine flounder (Paralichthys adspersus) subjected to compensatory growth trials as an experimental model. Furthermore, time-dependent effects of nutrition on plasma IGF-I levels, pathway activation, and growth parameters were evaluated.
MATERIAL AND METHODS

Chemicals
Protease inhibitor cocktail and pansorbin cells were purchased from Calbiochem-Novabiochem (San Diego, CA). Anti-ERK 1/2 (cat. no. sc-153) and anti-phospho-ERK 1/2 (cat. no. sc-23759) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Akt (cat. no. 9272), anti-phospho-Akt (cat. no. 9271), and anti-rabbit IgG HRP-linked (cat. no. 7074) antibodies were purchased from Cell Signalling (Beverly, MA). ECL Western blot analysis detection reagents and high-performance chemiluminescence films were purchased from GE Healthcare (Buckinghamshire, UK). Recombinant salmon IGF-I (sIGF-I) and anti-recombinant barramundi IGF-I primary antibody were purchased from GroPep (Adelaide, Australia). Human recombinant IGF-I (hIGF-I) used in the IGF-I in vivo administration were purchased from Austral Biologicals (San Ramon, CA). This recombinant mammalian hormone has nearly identical biological activity as has been described in previous studies (41, 18) .
Fish and Experimental Design
IGF-I in vivo administration. Juvenile fine flounders (P. adspersus; average weight 400 Ϯ 10 g) were obtained from the Centro de Investigación Marina de Quintay (CIMARQ; V Region, Valparaíso, Chile) to assess the effects of IGF-I on the activation of the MAPK/ ERK and the PI3K/Akt pathways. Twenty-four hours before IGF-I administration, food was withdrawn and no further food was given during the trial. A modification of the protocol outlined by Degger et al., (18) was followed for IGF-I injections. Fish were anesthetized with 3-aminobenzoic acid ethyl ester (100 mg/l), and a single injection of human recombinant IGF-I (0.3 g/ g body wt) or PBS (pH 7.4) was administered intraperitoneally.
Fasting and refeeding trials. Juvenile fine flounders (P. adspersus; average weight 200 Ϯ 10 g) were obtained from CIMARQ, passive integrated transpoder-tagged, and randomly divided among four tanks with each holding 50 fish. Fish were maintained under natural temperature and photoperiod conditions corresponding to the geographic location of CIMARQ (33°13=S; 71°38=W) during the summer season of 2009 in the southern hemisphere (February-March). Fish were fed once daily with 9-mm commercial pellet, containing 45% protein, 22% lipids, 16% carbohydrates, 1% crude fiber, 7% ashes, and 10% humidity (Skretting, Puerto Montt, Chile). The experimental design is shown in Fig. 1 . Prior to the trial, fish were acclimatized for 2 wk. At the start of the experiment (week 0), one group was fed until sated (0w group; continuously fed, control group), while food was withheld from the three other groups. At weeks 2, 3, and 4, one of the fasted groups was returned to satiety refeeding, creating groups fasted for 2 wk (2w group), 3 wk (3w group), and 4 wk (4w group). Each group was then followed over a 4-wk satiety refeeding period.
Sampling
IGF-I in vivo administration.
After 3 h of IGF-I administration, fish were killed using an overdose of 3-aminobenzoic acid ethyl ester (300 mg/l). White-fast myotomal muscle (50 g ) was excised at 0.50 fork length using a scalpel from IGF-I-treated fish and vehicle-PBS injected fish. Muscle was frozen immediately in liquid nitrogen and subsequently stored at Ϫ80°C until protein extraction.
Fasting and refeeding trials. Two sample series were collected during the trial, excluding the acclimatization period. For studying long-term effects of fasting and refeeding on plasma IGF-I levels and the activation of the signaling pathways, fish were sampled from each of the groups weekly 4 h after food supply (except the 3rd week of the refeeding period in the 2w, 3w, and 4w groups). To study the short-term effects of refeeding on plasma IGF-I levels and the activation of the signaling pathways, fish from each of the groups were sampled at 2, 4, and 24 h after the start of refeeding. For each group and time point, three individuals were sampled.
Fish were anesthetized (3-aminobenzoic acid ethyl ester, 100 mg/l), and blood was drawn from the caudal vessels with 1-ml heparinized syringes and centrifuged at 2,000 g for 5 min at 4°C to collect plasma. The plasma obtained was frozen in liquid nitrogen and stored at Ϫ80°C until hormone analysis.
After blood collection, fish were killed through an overdose (300 mg/l) of the same anesthetic. White-fast myotomal muscle (50 g ) was collected at 0.50 fork length using a scalpel. Tissue was frozen immediately in liquid nitrogen and subsequently stored at Ϫ80°C until protein extraction.
All sampling followed animal welfare procedures, and all experiments were approved by the bioethical committee of the Universidad Andres Bello and The National Commission for Scientific and Technological Research.
Growth assessment. Total length and body weight were measured at the beginning of the experiment, at the end of the fasting period, and at the end of the trial (end of the refeeding period). With these measurements, and to evaluate somatic growth in the fine flounder, the condition factor (CF) and the specific growth rate for weight (SGR w) were calculated. The condition factor was calculated as CF ϭ (W/L 3 ) ϫ 100, where W is the weight and L is the standard length and specific growth rate for weight was calculated as SGR w ϭ (LnW2 Ϫ LnW 1)/ (T2 Ϫ T1) ϫ 100, where W2 is the weight at the end of the growth period and W 1 is the weight at the beginning of the growth period, while T 2 Ϫ T1 represents the duration (in days) of the growing period.
Radioimmunoassay. Plasma IGF-I levels in the fine flounder during fasting and refeeding trials were measured by radioimmunoassay (RIA) in acid/ethanol-extracted plasma (60) , following the general protocol of Moriyama et al. (45) . Briefly, recombinant sIGF-I (GroPep) was used as a standard and label. Samples were diluted seven times after using the acid/ethanol procedure and subsequently diluted 2.8 times in the RIA procedure. Afterward, samples were incubated with the antirecombinant barramundi IGF-I primary antibody (1: 4,500; GroPep) for 24 h. Following the incubation, 100 l of the [ 125 I]-IGF-I containing 70 cpm/l was added. Antibody-hormone complexes were separated from free tracer by the addition of 0.25% pansorbin cells (Calbiochem-Novabiochem). Assay buffer (0.5% BSA and 0.05% Triton X-100 in PBS 0.02 M, pH 7.5) was then added and centrifuged for 1 h at 2,000 g at 4°C. The supernatant was aspirated and the precipitate was counted on a Wallac 1,470 gamma counter. Due to the high degree of IGF-I sequence conservation among fish species, heterologous RIA assay systems have been found to work across species (45) , and heterologous IGF-I RIAs have been previously used successfully to assess IGF levels in other flatfish species, such as Atlantic halibut (45) and turbot (29) . To validate the assay for the fine flounder, serial plasma dilutions were assessed, revealing good parallelism to the standard curve (Fig. 2) . The assay sensitivity, as indicated by ED80, ED50, and ED20 values, was 0.37, 1.15, and 3.15 ng/ml, respectively (n ϭ 4). The intra-and interassay coefficient of variation was 5.9% (n ϭ 10) and 8.1% (n ϭ 4), respectively.
Western blot analysis. Protein extracts from individual samples were prepared according to Valdes et al., (64) . Briefly, white-fast myotomal muscle (0.1 g) was homogenized at 4°C in 1 ml of lysis buffer containing 50 mM Tris·HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 5 mM Na3VO4, 20 mM NaF, 10 mM sodium pyrophosphate and a protease inhibitor cocktail from Calbiochem-Novabiochem (San Diego, CA). Protein concentration was determined by a modification of the Lowry assay (27) . Fifty micrograms of total protein were loaded per lane and resolved in 10% SDS-PAGEs.
Western blot assays were performed according Valdes et al., (64) . Briefly, proteins were transferred to polyvinylidene diflouride membranes (Millipore, Bedford, MA) and blocked for 1 h at room temperature in 5% nonfat milk dissolved in Tris-buffered saline. Primary antibody incubations were used at 1:500 [phosphorylated (p), pERK and pAkt] at 4°C overnight. After incubation with anti-rabbit IgG HRP-linked secondary antibody (1:1,000), for 1 h at room temperature, membranes were visualized by an enhanced chemiluminescence kit according to the manufacturer's instructions (GE Healthcare, Buckinghamshire, UK). Membranes were then stripped and blotted for total ERK or Akt antibody (1:500 and 1:1,000, respectively). Films were then scanned and densitometric analysis of the bands was performed with the Image J program (National Institutes of Health). Western blot analysis were carried out on three individual samples (n ϭ 3 per each group and time point), showing a representative blot film. To evaluate the activation of the MAPK/ERK and the PI3K/Akt pathways, results are presented as bar graphs, which represent means of individual densitometric analysis (n ϭ 3), using the phosphorylated form corrected with the total form (pERK/ERK and pAkt/Akt ratios), expressed as a fold change over basal levels found during the beginning of the trial (week 0).
To validate and confirm that commercial antibodies developed against mammalian epitopes cross react with samples of skeletal muscle of the fine flounder, comparative Western blot analyses were performed using rat myosatellite cell primary cultures as a control (Fig. 3) , showing that all commercial antibodies were able to detect their orthologs in the fine flounder, indicating an evolutionary conservation of these epitopes.
Statistical analysis. Results are expressed as means Ϯ SE. Statistical analysis used for the study of differences in growth parameters, IGF-I plasma levels, and activation of the MAPK/ERK and PI3K/Akt pathways were based on an advanced linear model. This model was the general linear model (GLM) with repeated measurements followed by Tukey's analysis as post test, using the STATISTICA 7 software (StatSoft, Tulsa, OK). A probability level of P Ͻ 0.05 and P Ͻ 0.01 was used to indicate statistical significance.
RESULTS
Growth Assessment During Fasting and Refeeding in the Fine Flounder
Growth parameters such as weight, CF, and SGR w were affected during the trial. For the control group; weight, CF, and SGR w increased during the trial. Particularly, weight increased from 212.41 Ϯ 1.78 to 228.27 Ϯ 1.81, CF was enhanced from 1.40 Ϯ 0.008 to 1.46 Ϯ 0.01, and SGR w was 0.13 Ϯ 0.035 from the start until the end of the trial. Length was not significantly modified in the control group. Likewise, these parameters were affected by fasting-refeeding trials, showing differences depending on the duration of the treatment (Fig. 4) . For the 2w group, body weight, length, and CF did not change significantly during the fasting-refeeding period. However, there was a significant effect on the SGR w during fasting (Ϫ0.233 Ϯ 0.046 and refeeding 0.11 Ϯ 0.024). The 3w group changed significantly in body weight, CF, and SGR w . Body weight decreased during fasting (196.11 Ϯ 1.74 g), but increased to full compensation after 4 wk of refeeding (219.06 Ϯ 2.27 g). This was reflected in similar changes on the CF (1.34 Ϯ 0.01 during fasting and 1.46 Ϯ 0.01 during refeeding), and no significant changes in length occurred. The compensatory weight gain is the result of a significantly higher SGR w during the refeeding period (0.25 Ϯ 0.019), compared with control fish. Also, the 4w group displayed significant differences in body weight, CF, and SGR w . Particularly, body weight decreased after 4 wk of fasting recovering partially after 4 wk of satiety feeding (188.77 Ϯ 1.98 during fasting and 202.43 Ϯ 2.73 during refeeding). On the other hand, a decreasing of the CF (1.27 Ϯ 0.03) and SGR w (Ϫ0.19 Ϯ 0.03) during fasting and a significant increase in both during refeeding was observed (1.40 Ϯ 0.01 for CF and 0.19 Ϯ 0.03 for SGR w ). No differences were observed in length.
In Vivo Effects of IGF-I on the Activation of ERK and Akt
Exogenous IGF-I was able to activate the MAPK/ERK and the PI3K/Akt signaling pathways in the skeletal muscle of the fine flounder. After 3 h postinjection, both ERK and Akt were activated 1.8-fold and 3.1-fold, respectively compared with the PBS-control group (Fig. 5) .
Plasmatic IGF-I Levels During Fasting and Refeeding in the Fine Flounder
During the long-term fasting and refeeding, plasma IGF-I levels decreased during fasting in a consistent manner; with a steady, gradual decrease, reaching the lowest levels at the end of the fasting period, where the decrease was significant for the 3w and 4w groups (Fig. 6A) . Following the start of refeeding for all fasted groups, plasma levels increased significantly after 1 wk in the 3w and 4w groups, and after 2 wk in the 2w group. In one instance, plasma IGF-I levels in the 3w group were higher at the end of the 4-wk refeeding period than those of the control group (Fig. 6A) . During the short-term refeeding (first 24 h) there was no a significant increase in plasma IGF-I in any of the treatments (Fig. 6B) .
MAPK/ERK and PI3K/Akt Signaling Pathways
The activation of the MAPK/ERK pathway was assessed through the ratio between the phosphorylated form of ERK1/2 and the total form of ERK1/2 (Fig. 7) . For the 0w control group, this ratio was constant over most of the study period, but increasing significantly (P Ͻ 0.05) toward the end (Fig. 7A) . Evaluating long-term fasting and refeeding effects on the ERK activation, fasted groups displayed a steady decrease in the activation of ERK 1/2 during the fasting period, with this decline becoming statistically significant at the end of the fasting period of the 3w and 4w groups (Fig. 7, B-D) . During the refeeding period, the pERK/ERK ratio was restored to prefasting levels. Short-term effects of refeeding on the activation of ERK during the first 24 h in the 2w, 3w, and 4w groups were observed; finding a higher activation in the 2w group in all time points compared with the 3w and 4w groups (Fig. 7, E, F, and G) . A: IGF-I plasma levels in the continuously fed control group and in fish subjected to long-term fasting and refeeding (2w, 3w, 4w groups). B: shortterm refeeding effects on IGF-I plasma levels. The 0-h period of the short-term refeeding denotes the end of the fasting period. The solid line indicates the continuously fed control group; and the long dash line, dotted line, and dash-dot line correspond to 2w, 3w, and 4w groups, respectively. Black symbols represent the fasting period and white symbols represent the feeding period. Values are expressed as means Ϯ SE (n ϭ 3). A GLM with repeated measurements, followed by a Tukey's post test indicated significant differences. Lowercase letters show a significance of P Ͻ 0.05 and uppercase letters show a significance of P Ͻ 0.01. Different letters mean significant differences between the points. Activation of the PI3K/Akt pathway was assessed through the ratio of phosphorylated Akt versus total Akt (Fig. 8) . In the 0w control group, the pAkt/Akt ratio was stable over the first part of the study, but increased steadily, becoming significant (P Ͻ 0.05), at the end of the trial (Fig. 8A) . To evaluate long-term effects of fasting and refeeding on Akt activation, fasted groups displayed a time-dependent inactivation of the PI3K/Akt pathway, with the pAkt/Akt ratio being significantly decreased at the end of the fasting period for the 3w and 4w groups (Fig. 8, B-D) . Following refeeding of the fasted groups, there was a rebounding increase in activation, which was significant (P Ͻ 0.05) after 1 wk for the 3w and 4w groups, respectively (Fig. 8, C and D) . To assess short-term effects of refeeding on the activation of Akt, three time-points were evaluated during the first 24 h. Akt was activated during the first 24 h in the 2w, 3w, and 4w groups, observing a higher activation in the 2w group in all time points compared with the 3w and 4w groups (Fig. 8, E-G) .
In this study it was observed that IGF-I plasma levels, the activation of the MAPK/ERK, and the PI3K/Akt signaling pathways in muscle and growth parameters (e.g., body weight, CF, and SGR w ) decreased during fasting, whereas all of these parameters increased during refeeding, finding that fish with lower growth parameters present lower IGF-I plasma levels and lower activation of ERK and Akt, phenomenon that is reverted in fish with higher growth parameters.
DISCUSSION
Many fish species naturally experience prolonged periods of anabolic and catabolic nutritional conditions, depending on random or seasonal variation in prey abundance. The present study simulates this by withholding food from groups of fine flounder for 2-4 wk, followed by a 4-wk refeeding period. This demonstrates for the first time in a nonmammalian species that the MAPK/ERK pathway activation is regulated by nutritional status and inhibited during fasting and stimulated during refeeding. Also, this study establishes a link between plasma IGF-I, the activation of the MAPK/ERK and the PI3K/Akt pathways in fish skeletal muscle, and somatic growth in the Fig. 8 . The PI3K/Akt signaling pathway during fasting and refeeding. A: continuously fed control group (0w group). B-D; long-term effects of fasting and refeeding on the activation of Akt in the 2w, 3w, 4w groups, respectively. E-G: short-term effects of refeeding on the activation of Akt in the 2w, 3w, 4w groups, respectively. The 0-h period of the short-term refeeding denotes the end of the fasting period (E-G). Black bars represent the fasting period and white bars represent the feeding period. Values are expressed as means Ϯ SE (n ϭ 3 per each time). A GLM with repeated measurements, followed by Tukey's post test, indicated significant differences. Lowercase letters show a significance of P Ͻ 0.05 and uppercase letters show a significance of P Ͻ 0.01. fine flounder, strongly suggesting functional and regulatory relationships.
Growth Assessment in the Fine Flounder
Fasting and refeeding trials trigger compensatory growth, which is a complex phenomenon that shows different degrees of compensation depending on feeding protocols, including length and intensity of deprivation (1, 6) . This phenomenon was observed in fine flounder subjected to different periods of fasting. The fine flounder exhibits low metabolic rates that are associated with their benthic and sedentary lifestyle. These features make the fine flounder less susceptible to short periods of fasting and might explain minor changes in growth parameters after 2 wk of fasting. On the other hand, fine flounders fasted for the 3 wk start to be affected by starving, but not critically, allowing the flounder to recover during refeeding, and, as a consequence, triggering full compensation of growth. The group subjected to 4 wk of fasting exhibited higher body mass lost, causing only a partial compensation of growth, probably due to one more week of fasting, causing critical effects. These critical effects might be related with a major replacement of lipids by protein as the major metabolic fuel, compared with 3 wk of fasting, triggering muscle atrophy (3), and therefore not allowing the fine flounder to catch-up this loss during the refeeding term. On the other hand, all growth parameters increased in the control group. This phenomenon might be due to the fact that fish grew better during that period, possibly due to changes throughout the trial in the environmental conditions (e.g., photoperiod and temperature) and feeding behavior (e.g., fine flounders change eating behavior and eat more during summer).
IGF-I Plasma Levels
Fasting causes a gradual and progressive decline in plasma IGF-I levels with changes being significant after 3-4 wk of fasting, in agreement with previous studies on other teleost species (12, 20, 44) . Following the start of refeeding, plasma IGF-I increases rapidly, with a general trend toward overshooting the plasma IGF-I levels in continuously fed controls (significant only after 4 wk). Interestingly, the 3w group showed an overcompensation of plasma IGF-I levels at the end of the trial, which coincides with the fact that the 3w group was the only one able to fully compensate growth. This full catch-up might be due to higher plasma IGF-I levels. These results confirm the importance of nutritional status for plasma IGF-I levels (12, 20, 44) and show differential regulation of circulating amounts of IGF-I depending on the extension of catabolic-fasting periods.
MAPK/ERK and PI3K/Akt Signaling Pathways
The present data indicate that the MAPK/ERK and the PI3K/Akt pathways in skeletal muscle are both regulated in a similar manner, linked to nutritional status. Muscle is a complex tissue made up of several cell types, such as connective tissue, fibroblast, satellite cells, immature myotubes, and mature fibers (8, 24, 35) . In fish, the proportion of these components depends on size, growth status, and species, with immature myotubes and maturing fibers predominant over other cell types (33) . The skeletal muscle used in the present study was obtained from juvenile fine flounders, where a complex mixture of muscle cells, mainly represented by myotubes, should be found. In vitro studies in mammals have shown that the MAPK/ERK and the PI3K/ Akt pathways exert different effects and act in different phases of myogenesis in myosatellite cell cultures (14) . In vivo approaches have described that the inhibition of the MAPK/ERK pathway prevents IGF-I-induced hypertrophy, showing that there are interactions between various pathways downstream of the IGF-I receptor, which may switch differently in vivo than in vitro (26) , suggesting that the activation of both pathways may be contributing to hypertrophic muscle growth in flounder.
Fasting effects on the activation of the MAPK/ERK in skeletal muscle have not been described. However, other approaches, such as caloric restriction protocols have been shown. In monkeys subjected to a 40% caloric restriction diet, which prevents weight gain and protects middle-age onset obesity, the activation of ERK in skeletal muscle increases (47) , showing an opposite effect than that of fasting. Effects of fasting on the activation of Akt and other downstream components (e.g., mTOR, S6K1, and 4EBP1) in mammalian skeletal muscle show a decrease (2, 65) . In fish, particularly in rainbow trout, Akt phosphorylation decreases after 2 wk of fasting and increases rapidly after 2 h of refeeding (58), in agreement with the present study. During short-term refeeding, both pathways are activated in muscle in all studied groups, as was described previously in rainbow trout (57, 58) . However, a different pattern in the activation of both pathways, which depends on the extension of the fasting period, was found for the first time. Particularly, the 2w group showed higher activation of ERK and Akt compared with the 3w, and 4w groups in all of the time points. Plasma IGF-I levels and the activation of the MAPK/ERK and the PI3K/Akt signaling pathways follow a similar pattern during fasting and the long-term refeeding in all the groups of fish studied. This suggests that the activation of both pathways could be modulated through the endocrine system of growth, mainly through IGF-I during these periods. However, plasma IGF-I levels do not follow the same pattern as the activation of both pathways during the short-term refeeding; actually, circulating levels of IGF-I do not change significantly during the first 24 h after food administration. Other studies using rainbow trout as a model have also reported that IGF-I does not display a short-term response during refeeding (20) . However, hormones such as insulin and IGF-II display a rapid increase in circulating levels during the shortterm refeeding (24 h). Particularly, the degree of this enhancement in insulin is influenced by the extension of the fasting period (61) . For instance, fish subjected to longer periods of fasting (3 wk) show lower levels of insulin in plasma during short-term refeeding than fish subjected to shorter periods of fasting (1 wk) (61) . In the present study, insulin and IGF-II were not measured; nevertheless both signaling pathways show a higher activation in fish subjected to short periods of fasting (e.g., 2w group) than fish subjected to more extended periods (e.g., 3w and 4w group). Thus, it is possible to hypothesize that IGF-II and/or insulin might be activating both pathways with different intensities during the short-term refeeding depending on the extension of fasting.
IGF-I/MAPK/ERK and IGF-I/PI3K/Akt Pathways and Somatic Growth
Studies using in vivo trials administrating IGF-I in fish have been scarce, particularly those that have evaluated the effects of this hormone on skeletal muscle. In the present study, the injection of human recombinant IGF-I significantly stimulates the activation of the MAPK/ERK and the PI3K/Akt in skeletal muscle, showing for the first time that IGF-I is able to stimulate the phosphorylation and, consequently, the activation of ERK and Akt in fish skeletal muscle in vivo. In barramundi fish, IGF-I stimulates protein synthesis in muscle in vivo (18) ; and in rainbow trout IGF-I prevents fasting-induced weight loss through decreasing protein degradation via downregulation of MAFbx (F-box)-E3 ubiquitin-ligase and proteosomal mRNAs in vivo (12) . Altogether, the present and previous studies show that circulating levels of IGF-I have direct effects in fish skeletal muscle, which suggests that circulating IGF-I can have an important role in muscle growth. However, autocrine/paracrine IGF-I may also have an important role in fish muscle growth as has been previously suggested (7) , as well as in mammals, where autocrine/paracrine-produced IGF-I appears to be more important than circulating levels in stimulating muscle growth (59, 68) .
In the present study, IGF-I plasma levels, the activation of the MAPK/ERK, and the PI3K/Akt pathways in skeletal muscle and somatic growth display a similar pattern. Thus fish with low IGF-I plasma levels display lower activation of both pathways and lower growth parameters, and vice versa. This pattern is observed in all groups, but particularly in the control and 3w group. In the control group, plasma IGF-I levels and its signaling pathways increase during the trial together with growth parameters. On the other hand, the 3w group showed at the end of the trial an overcompensation of plasma IGF-I levels and a higher activation of Akt, which coincides with the fact that 3w group was the only one able to fully compensate growth. Several studies have pointed out a significant and positive correlation between circulating IGF-I and growth rates in different fish species (4, 34, 41, 51, 60, 62, 66) . Moreover, both homologous and heterologous IGF-I promote growth in teleosts (41, 17, 18) , and this growth promotion in skeletal muscle is through the activation of ERK and Akt (5, 26) , suggesting that the IGF-I/MAPK/ERK and the IGF-I/PI3K/Akt pathways in skeletal muscle could be used as molecular markers of whole fish growth. This is due to the fact that skeletal muscle in fish comprises the largest single tissue compartment, representing 40 -60% of total body mass, a relatively larger component than of that in mammals (31) . Therefore, for fish, body mass is strongly related to muscle mass (28, 31) , highlighting the importance of the activation of the MAPK/ERK and the PI3K/Akt pathways in this tissue and its contribution to the growth of the whole fish. In mammals, both pathways induce somatic growth via skeletal muscle growth. The MAPK/ERK signaling pathway is involved in myoblast proliferation (30) and muscle differentiation (25, 39) . On the other hand, the PI3K/Akt pathway promotes hypertrophy of muscle fibers by means of the activation of mTOR and the glycogen synthase kinase 3␤ (GSK-3␤) (21, 22) ; concomitantly with blocking skeletal muscle atrophy through the inhibition of FOXO and consequently the E3 ubiquitin ligases (23, 37) . Furthermore, all of the growth-promoting actions of the MAPK/ERK and PI3K/Akt pathways described above are mainly regulated by IGF-I (14, 21, 22, 26, 23) . In fish, IGF-I activates the MAPK/ERK and the PI3K/Akt pathways in muscle cell primary cultures (10, 13, 43) , and we show for the first time that this growth factor carries out the same function in vivo. Moreover, IGF-I in fish acts as an inhibitor of proteolysis, promoting protein accretion as in mammals (11, 12) . Therefore, taken altogether, the present results and previous literature suggest that low plasma levels of nutritionally regulated IGF-I can cause the inactivation of the MAPK/ERK and the PI3K/Akt pathways during the fasting period. Thus, the inactivation of these pathways might induce a decrease in skeletal muscle growth, causing muscle atrophy concomitantly with loss of somatic growth. On the other hand, high levels of plasma IGF-I can be activating both pathways during the refeeding, promoting muscle mass growth, probably by hypertrophy, and, consequently, somatic growth. Therefore, the results obtained strongly suggest a role of plasma IGF-I and its signaling pathways in muscle in somatic growth in the fine flounder.
Conclusions, Significance and Future Perspectives
The present study demonstrates for the first time that circulating exogenous IGF-I stimulates the activation of the MAPK/ ERK and the PI3K/Akt pathways in fish skeletal muscle. Moreover, we have found that the activation of the MAPK/ ERK and PI3K pathways are regulated by nutritional status. Furthermore, this study reveals a time-dependent modulation of IGF-1 and its pathways, and strongly suggests that the IGF-I/MAPK/ERK and the IGF-I/PI3K/Akt pathways in skeletal muscle contribute to somatic growth in fish. These findings contribute to the knowledge of how nutrition regulates IGF-I, its signaling pathways, and their actions controlling somatic growth in nonmammalian species. However, the detailed role of these signaling pathways in the hyperplasic and/or hypertrophic muscle growth remains to be determined, as well as if the activation of the MAPK/ERK is directly mediated by nutrients (e.g., amino acids) and/or indirectly regulated via IGF-I or other growth factors.
